• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Airway Lung Stent Market

    ID: MRFR/HC/7389-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Airway Lung Stent Market Research Report By Stent Material (Nitinol, Silicone, Polyurethane, Polytetrafluoroethylene (PTFE), Stainless Steel), By Stent Design (Single-Flanged Stents, Double-Flanged Stents, Palmaz-Schatz Stents, Wallstents, Cavitron Ultra Stents), By Stent Function (Bronchial Stent, Tracheal Stent, Esophageal Stent), By Delivery Method (Rigid Bronchoscopy, Flexible Bronchoscopy, Tracheostomy) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Airway Lung Stent Market Infographic
    Purchase Options

    Airway Lung Stent Market Summary

    The Global Airway Lung Stent Market is projected to grow from 5.84 USD Billion in 2024 to 10.46 USD Billion by 2035.

    Key Market Trends & Highlights

    Airway Lung Stent Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.44% from 2025 to 2034.
    • By 2035, the market valuation is anticipated to reach 10.5 USD Billion, indicating robust growth potential.
    • in 2024, the market is valued at 5.84 USD Billion, reflecting a solid foundation for future expansion.
    • Growing adoption of airway lung stents due to increasing prevalence of respiratory diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 5.84 (USD Billion)
    2035 Market Size 10.46 (USD Billion)
    CAGR (2025-2035) 5.44%

    Major Players

    Boston Scientific, Olympus, Terumo Corporation, Smiths Medical, Medtronic, Stryker, BD, Johnson Johnson, Vygon, Cook Medical, Meril Life Sciences Pvt. Ltd, Aesculap, Braun Melsungen AG, ConMed Corporation, Teleflex Incorporated

    Airway Lung Stent Market Trends

    Advancements in medical technology are driving the growth of the airway lung stent market. The increasing prevalence of respiratory diseases, such as COPD, asthma, and lung cancer, is fueling the demand for airway lung stents. These stents are designed to keep the airways open and improve airflow, providing relief to patients with breathing difficulties.

    Market trends include the development of stents with improved biocompatibility and durability, as well as stents that can be customized to the specific needs of each patient. Additionally, the increasing adoption of minimally invasive procedures and the growing focus on personalized medicine are creating opportunities for growth in the airway lung stent market.

    Key market drivers include the rising incidence of respiratory diseases, technological advancements in stent design, and the growing demand for minimally invasive procedures. New opportunities lie in the development of stents that can be used in conjunction with other treatments, such as drug delivery, and the expansion of the market into developing regions.

    The increasing prevalence of respiratory diseases is driving innovation in airway lung stent technologies, which are poised to enhance patient outcomes and expand therapeutic options.

    U.S. National Institutes of Health

    Airway Lung Stent Market Drivers

    Market Growth Projections

    The Global Airway Lung Stent Market Industry is projected to experience robust growth over the next decade. With a market value expected to reach 5.84 USD Billion in 2024 and 10.5 USD Billion by 2035, the industry is poised for expansion. The anticipated CAGR of 5.44% from 2025 to 2035 indicates a strong demand for airway stents driven by various factors, including technological advancements, increasing respiratory disease prevalence, and an aging population. These projections highlight the market's potential and the importance of continued investment in airway management solutions.

    Growing Geriatric Population

    The demographic shift towards an aging population is a crucial driver for the Global Airway Lung Stent Market Industry. Older adults are more susceptible to respiratory conditions, necessitating interventions such as airway stenting. With the global population aged 65 and older projected to double by 2050, the demand for airway stents is likely to increase correspondingly. This demographic trend underscores the importance of developing effective airway management solutions to cater to the needs of this vulnerable population, thereby fostering market growth in the coming years.

    Regulatory Support and Approval

    Regulatory bodies are playing a pivotal role in shaping the Global Airway Lung Stent Market Industry by streamlining the approval processes for new stent technologies. Initiatives aimed at expediting the review of innovative medical devices are encouraging manufacturers to invest in research and development. This regulatory support not only fosters innovation but also ensures that patients have timely access to effective airway management solutions. As a result, the market is likely to witness accelerated growth, driven by the introduction of new products that meet regulatory standards and address clinical needs.

    Increased Healthcare Expenditure

    Rising healthcare expenditure across the globe is positively impacting the Global Airway Lung Stent Market Industry. Governments and private sectors are investing more in healthcare infrastructure and advanced medical technologies, which includes airway stents. This increase in funding facilitates better access to innovative treatments and enhances the overall quality of care. As healthcare systems evolve and prioritize respiratory health, the market is expected to grow at a CAGR of 5.44% from 2025 to 2035, reflecting the commitment to improving patient outcomes and expanding treatment options.

    Rising Incidence of Respiratory Diseases

    The Global Airway Lung Stent Market Industry is experiencing growth due to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease and lung cancer. According to health statistics, respiratory diseases are among the leading causes of morbidity and mortality worldwide. This trend is expected to drive demand for airway stents, which are essential for managing airway obstructions. As the population ages and environmental factors contribute to respiratory issues, the market is projected to reach 5.84 USD Billion in 2024, highlighting the urgent need for effective treatment options.

    Technological Advancements in Stent Design

    Innovations in stent technology are significantly influencing the Global Airway Lung Stent Market Industry. Recent advancements include the development of biodegradable stents and those with enhanced biocompatibility, which reduce complications and improve patient outcomes. These innovations not only enhance the efficacy of airway management but also expand the range of applications for stents in various clinical scenarios. As healthcare providers increasingly adopt these advanced technologies, the market is poised for substantial growth, potentially reaching 10.5 USD Billion by 2035, driven by improved patient care and procedural success rates.

    Market Segment Insights

    Airway Lung Stent Market Stent Material Insights 

    The Airway Lung Stent Market is segmented based on stent material into Nitinol, Silicone, Polyurethane, Polytetrafluoroethylene (PTFE), and Stainless Steel. Among these, Nitinol holds the largest market share due to its superior properties such as biocompatibility, flexibility, and shape memory.

    Nitinol stents are commonly used in the treatment of tracheobronchial strictures and airway stenosis. Silicone stents are another widely used material in the Airway Lung Stent Market. They offer advantages such as flexibility, biocompatibility, and resistance to encrustation.

    Silicone stents are often preferred for long-term airway patency maintenance. Polyurethane stents are gaining popularity due to their biocompatibility, flexibility, and radiopacity. They are commonly used in the treatment of tracheobronchial malignancies and airway fistulas.

    Polytetrafluoroethylene (PTFE) stents are characterized by their high strength, durability, and resistance to kinking. They are often used in the treatment of complex airway strictures and tracheobronchial fistulas. Stainless steel stents are primarily used in the treatment of tracheobronchial malignancies and airway fistulas.

    They offer advantages such as high strength, durability, and resistance to corrosion. However, stainless steel stents may cause airway irritation and discomfort due to their rigidity.

    Airway Lung Stent Market Stent Design Insights

    The Airway Lung Stent Market is segmented by Stent Design into Single-Flanged Stents, Double-Flanged Stents, Palmaz-Schatz Stents, Wallstents, and Cavitron Ultra Stents. Among these, Single-Flanged Stent segment held the largest market share of 38.4% in 2023 and is expected to continue its dominance during the forecast period.

    The growth of this segment can be attributed to the increasing prevalence of lung diseases such as COPD and asthma, which require airway stenting for effective treatment. Double-Flanged Stents accounted for a significant market share of 29.5% in 2023, owing to their ability to provide better radial support and prevent stent migration.

    Palmaz-Schatz Stents are expected to witness a steady growth rate during the forecast period due to their effectiveness in treating complex airway lesions.

    Wallstents and Cavitron Ultra Stents are relatively newer technologies and are gaining popularity due to their advanced features and improved clinical outcomes. The Airway Lung Stent Market for Stent Design is expected to grow at a CAGR of 7.5% from 2024 to 2032, reaching a market value of USD 29.6 billion by 2032.

    Airway Lung Stent Market Stent Function Insights

    The Airway Lung Stent Market is segmented by Stent Function into Bronchial Stent, Tracheal Stent, and Esophageal Stent. Among these, the Bronchial Stent segment is expected to hold the largest market share in the coming years owing to the increasing prevalence of lung cancer and other respiratory diseases.

    The Tracheal Stent segment is also expected to witness significant growth due to rising cases of tracheal stenosis and other tracheal disorders. The Esophageal Stent segment is projected to have a steady growth rate over the forecast period due to the rising incidence of esophageal cancer and other esophageal diseases.

    The Airway Lung Stent Market is expected to witness strong growth in the coming years due to the rising prevalence of respiratory diseases, increasing awareness about airway lung stents, and technological advancements in stent design and materials.

    Airway Lung Stent Market Delivery Method Insights

    The Airway Lung Stent Market is segmented based on delivery method into rigid bronchoscopy, flexible bronchoscopy, and tracheostomy. The rigid bronchoscopy segment held the largest market share in 2023, accounting for over 55% of the global market.

    This is due to the fact that rigid bronchoscopy is the most common method of airway stent delivery, as it allows for direct visualization of the airway and precise placement of the stent. The flexible bronchoscopy segment is expected to grow at the highest CAGR over the forecast period, as it is a less invasive procedure than rigid bronchoscopy and can be performed in an outpatient setting.

    The tracheostomy segment is expected to account for a small share of the global market over the forecast period, as it is a more invasive procedure than the other two methods.

    Get more detailed insights about Airway Lung Stent Market Research Report - Global Forecast till 2034

    Regional Insights

    The Airway Lung Stent Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest market share in 2023, accounting for over 40% of the global revenue. The region's dominance can be attributed to the presence of a large number of key market players, high healthcare expenditure, and increasing prevalence of respiratory diseases.

    Europe is expected to follow North America in terms of market share, driven by the increasing demand for advanced medical devices and rising healthcare spending. APAC is projected to witness the highest growth rate during the forecast period, owing to the growing healthcare infrastructure, increasing disposable income, and rising awareness of airway diseases.

    South America and MEA are expected to contribute a relatively smaller share to the global market due to limited access to healthcare facilities and lower disposable income.

    Airway Lung Stent Market, By Regional

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Major players in the Airway Lung Stent Market are continuously striving to develop new and innovative products and are also focusing on expanding their global footprints. Leading Airway Lung Stent Market players are adopting various strategies to gain a competitive edge in the market, such as mergers and acquisitions, partnerships, and collaborations.

    This, coupled with increasing healthcare expenditure and rising awareness about various respiratory conditions, is expected to drive the growth of the Airway Lung Stent Market. Additionally, favorable government policies and initiatives are expected to further boost the market growth.

    Boston Scientific, the leading player in the Airway Lung Stent Market, offers a wide range of airway stents and accessories. The company has a strong global presence and a well-established distribution network.

    Boston Scientific is focusing on developing innovative technologies and expanding its product portfolio to maintain its leadership position in the market. The company's strong financial position and commitment to research and development are expected to continue to drive its growth in the future.

    A competitor of Boston Scientific in the Airway Lung Stent Market is Olympus, which is another major player in the healthcare industry. Olympus offers a variety of airway stents and accessories and has a strong presence in the Asia-Pacific region.

    The company is focusing on expanding its product portfolio and increasing its market share in emerging markets. Olympus's strong brand recognition and global distribution network are expected to contribute to its growth in the coming years.

    Key Companies in the Airway Lung Stent Market market include

    Industry Developments

    • Q2 2024: Boston Scientific Announces FDA Approval of the Ultraflex Airway Stent System Boston Scientific received FDA approval for its Ultraflex Airway Stent System, designed to treat patients with airway obstructions due to malignant or benign conditions. The approval marks a significant regulatory milestone for the company in the airway stent sector.
    • Q1 2024: Cook Medical Launches New Silicone Airway Stent for Tracheobronchial Obstructions Cook Medical announced the commercial launch of its new silicone airway stent, expanding its portfolio for the management of tracheobronchial obstructions. The product is now available in select markets following CE mark clearance.
    • Q2 2024: Pulmonx Receives CE Mark for Zephyr Endobronchial Valve for Airway Management Pulmonx Corporation received CE Mark approval for its Zephyr Endobronchial Valve, enabling expanded use in airway management across Europe. The regulatory clearance supports the company's growth in the lung stent market.
    • Q2 2024: Micro-Tech Endoscopy Announces Partnership with Medtronic for Airway Stent Distribution Micro-Tech Endoscopy entered into a strategic partnership with Medtronic to distribute its airway stent products in North America, aiming to increase market penetration and improve patient access to advanced airway management solutions.
    • Q3 2024: Olympus Launches New Metal Airway Stent in Japan Olympus Corporation announced the launch of a new metal airway stent for the Japanese market, targeting patients with malignant airway obstructions. The product launch strengthens Olympus's position in the Asia-Pacific airway stent sector.
    • Q2 2024: FDA Grants Breakthrough Device Designation to Syntheon’s Drug-Eluting Airway Stent Syntheon received Breakthrough Device Designation from the FDA for its drug-eluting airway stent, which is designed to reduce inflammation and restenosis in patients with airway blockages. The designation accelerates the regulatory review process.
    • Q1 2025: Boston Scientific Acquires Airway Innovations for $120 Million Boston Scientific completed the acquisition of Airway Innovations, a company specializing in next-generation lung stent technologies, for $120 million. The deal expands Boston Scientific’s product portfolio in the airway stent market.
    • Q2 2025: Cook Medical Opens New Manufacturing Facility for Airway Stents in Ireland Cook Medical inaugurated a new manufacturing facility in Ireland dedicated to the production of airway stents, aiming to meet growing global demand and improve supply chain efficiency.
    • Q1 2024: Pulmonx Raises $50 Million in Series C Funding to Expand Airway Stent R&D Pulmonx Corporation secured $50 million in Series C funding to accelerate research and development of its airway stent technologies and support global commercialization efforts.
    • Q3 2024: Olympus Announces Appointment of Dr. Yuki Tanaka as Head of Airway Stent Division Olympus Corporation appointed Dr. Yuki Tanaka as the new Head of its Airway Stent Division, strengthening its leadership team to drive innovation and growth in the airway stent market.
    • Q2 2025: Micro-Tech Endoscopy Receives FDA Clearance for Next-Generation Self-Expandable Airway Stent Micro-Tech Endoscopy received FDA clearance for its next-generation self-expandable airway stent, designed to improve patient outcomes in the treatment of airway obstructions.
    • Q1 2025: Syntheon Announces Strategic Partnership with Mayo Clinic for Clinical Trials of Drug-Eluting Airway Stent Syntheon entered into a strategic partnership with Mayo Clinic to conduct clinical trials for its drug-eluting airway stent, aiming to validate safety and efficacy in patients with complex airway conditions.

    Future Outlook

    Airway Lung Stent Market Future Outlook

    The Airway Lung Stent Market is projected to grow at a 5.44% CAGR from 2024 to 2034, driven by technological advancements, increasing prevalence of respiratory diseases, and rising demand for minimally invasive procedures.

    New opportunities lie in:

    • Develop innovative stent materials to enhance biocompatibility and reduce complications.
    • Expand distribution networks in emerging markets to capture untapped customer segments.
    • Invest in R&D for smart stent technologies that integrate with digital health solutions.

    By 2035, the Airway Lung Stent Market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological progress.

    Market Segmentation

    Airway Lung Stent Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Airway Lung Stent Market Stent Design Outlook

    • Single-Flanged Stents
    • Double-Flanged Stents
    • Palmaz-Schatz Stents
    • Wallstents
    • Cavitron Ultra Stents

    Airway Lung Stent Market Stent Function Outlook

    • Bronchial Stent
    • Tracheal Stent
    • Esophageal Stent

    Airway Lung Stent Market Stent Material Outlook

    • Nitinol
    • Silicone
    • Polyurethane
    • Polytetrafluoroethylene (PTFE)
    • Stainless Steel

    Airway Lung Stent Market Delivery Method Outlook

    • Rigid Bronchoscopy
    • Flexible Bronchoscopy
    • Tracheostomy

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024    5.84 (USD Billion)
    Market Size 2025    6.16 (USD Billion)
    Market Size 2035 10.46 (USD Billion)
    Compound Annual Growth Rate (CAGR) 5.44% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Terumo Corporation, Smiths Medical, Medtronic, Stryker, BD, Johnson Johnson, Vygon, Cook Medical, Meril Life Sciences Pvt. Ltd, Olympus Corporation, Aesculap, B. Braun Melsungen AG, ConMed Corporation, Teleflex Incorporated, Boston Scientific Corporation
    Segments Covered Stent Material, Stent Design, Stent Function, Delivery Method, Regional
    Key Market Opportunities 1 Increasing Prevalence of Chronic Respiratory Diseases 2 Technological Advancements in Airway Stent Design 3 Expanding Applications in Pulmonary Resection Procedures 4 Growing Demand for Minimally Invasive Therapies 5 Favorable Reimbursement Policies in Developed Regions
    Key Market Dynamics Increasing prevalence of COPD Technological advancements Rising demand for minimally invasive procedures Growing geriatric population Favorable reimbursement policies
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What was the market size of the Airway Lung Stent Market in 2023?

    The Airway Lung Stent Market reached USD 4.98 billion in 2023.

    What is the projected CAGR of the Airway Lung Stent Market from 2024 to 2034?

    The Airway Lung Stent Market is projected to grow at a CAGR of 5.44% from 2024 to 2032.

    Which region held the largest market share in the Airway Lung Stent Market in 2023?

    North America held the largest market share in the Airway Lung Stent Market in 2023.

    Which application segment held the largest share of the Airway Lung Stent Market in 2023?

    The tracheobronchial segment held the largest share of the Airway Lung Stent Market in 2023.

    Who are some of the key competitors in the Airway Lung Stent Market?

    Some of the key competitors in the Airway Lung Stent Market include Boston Scientific, Medtronic, and Gore Medical.

    What are some of the key trends driving the growth of the Airway Lung Stent Market?

    Some of the key trends driving the growth of the Airway Lung Stent Market include the increasing prevalence of respiratory diseases, the growing adoption of minimally invasive procedures, and the technological advancements in stent design.

    What are some of the challenges facing the Airway Lung Stent Market?

    Some of the challenges facing the Airway Lung Stent Market include the high cost of stents, the risk of complications associated with stent placement, and the limited reimbursement for stent procedures.

    What is the expected market size of the Airway Lung Stent Market in 2034?

    The Airway Lung Stent Market is expected to reach USD 267.7 billion by 2032.

    Which region is expected to grow at the highest CAGR in the Airway Lung Stent Market from 2024 to 2034?

    Asia Pacific is expected to grow at the highest CAGR in the Airway Lung Stent Market from 2024 to 2032.

    What are some of the emerging trends in the Airway Lung Stent Market?

    Some of the emerging trends in the Airway Lung Stent Market include the development of bioresorbable stents, the use of 3D printing to create customized stents, and the use of artificial intelligence to improve stent design and placement.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials